CCO

0.00%

0.9¢ the calmer co international limited

Ann: Quarterly Activity and Cashflow Reports, page-80

First 80 Last

Share
Profile

Follow
New Trader

1,752 Posts.

52

30/10/20

13:33

Post #: 48527579
Share

Originally posted by JAar ↑

I think he is just looking for an excuse to sell. FIJ like all stocks in the speccy space are not valued on their current revenue generation, but their potential to grow. Does a stock like WBT even have any revenue?

One new deal announced should see us back at 30c+ once people realise the pedigree of the FIJ management team. Of course if the deal is large then 40c is back on the cards short term.

I'd love to buy down here but I'm waiting for the dust to settle from the election before splurging on bargains.

Expand

Originally posted by Leapzig ↑

Some of the loyal holders showing their true colours.

Considering some of the very poor quarterly results, FIJ at this early stage of its career has faired rather well. I think you will find this has been oversold and will rebound quickly. As I have said previously if they get marketing right and appoint a hard working CEO with a good network and preferably a proven track record with growth and sales of supplements then they will succeed. I like their caution entering China, its a tough market at the moment. Take a look at Bubs, its in real trouble.

Expand

Agree totally, have not sold any -always has been a long term hold for me.....

Little companies like this can move fast in either direction, no point trading it just hold for long term gains...

I will say however that it never ceases to amaze me how/why people get so emotionally involved in a particular stock, it has had one bad week and peeps carry on like their dog just died....

Btw, what happened to all the prolific rampers on this thread? @fareki , @Stockholm, @unsinkable I'm looking at you...lol

FIJ Price at posting: 17.0¢ Sentiment: Buy Disclosure: Held
6 Upvote

1 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BUX

Buxton projects new graphite province discovery at WA Narryer play

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

There are more pages in this discussion • 10 more messages in this thread...

First 80 Last

Add CCO (ASX) to my watchlist

(20min delay)
Last 0.9¢		Change 0.000(0.00%)		Mkt cap ! $19.81M

Open	High	Low	Value	Volume
0.9¢	1.0¢	0.9¢	$22.41K	2.404M

Buyers (Bids)

No.	Vol.	Price($)
1	90392	0.9¢

Sellers (Offers)

Price($)	Vol.	No.
1.0¢	7377689	8

View Market Depth

No.	Vol.	Price($)
1	90392	0.009
10	3631914	0.008
7	3942856	0.007
4	1642300	0.006
1	90000	0.005

Price($)	Vol.	No.
0.010	7377689	8
0.011	15286503	18
0.012	3550000	3
0.013	5501596	3
0.014	71500	1

Last trade - 16.10pm 04/10/2024 (20 minute delay)

CCO (ASX) Chart

Ann: Quarterly Activity and Cashflow Reports, page-80

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Activity and Cashflow Reports, page-80

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News